# Electrophysiologic Measures of Treatment Response in Alzheimer Disease

> **NCT00018278** · PHASE4 · COMPLETED · sponsor: **US Department of Veterans Affairs**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Aricept
- **DRUG:** Exelon
- **DRUG:** Nicoderm Patch

## Key facts

- **NCT ID:** NCT00018278
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** 2001-09
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018278, "Electrophysiologic Measures of Treatment Response in Alzheimer Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00018278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*